For research use only. Not for therapeutic Use.
Trelagliptin succinate (Cat.No:I000181) is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes mellitus. It works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones like GLP-1 and GIP. Trelagliptin succinate helps to regulate blood sugar levels and is administered orally as a once-weekly medication.
| Catalog Number | I000181 |
| CAS Number | 1029877-94-8 |
| Synonyms | 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile;butanedioic acid |
| Molecular Formula | C₂₂H₂₆FN₅O₆ |
| Purity | ≥95% |
| Target | Dipeptidyl Peptidase |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile;butanedioic acid |
| InChI | InChI=1S/C18H20FN5O2.C4H6O4/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20;5-3(6)1-2-4(7)8/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3;1-2H2,(H,5,6)(H,7,8)/t15-;/m1./s1 |
| InChIKey | OGCNTTUPLQTBJI-XFULWGLBSA-N |
| SMILES | CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N.C(CC(=O)O)C(=O)O |
| Reference | <p style=/line-height:25px/> |
